This week we explore the Food and Drug Administration’s new guidance related to single trial approvals and the National Institutes of Health’s commencement of a trial for a universal flu vaccine. We also look at the start of clinical trials for CRISPR-based leukemia treatment and the FDA’s rejection of a ... READ MORE >
medtech
5 things to know in life sciences: Week of Sept. 11, 2023
This week we explore the approval of updated COVID-19 vaccines, the announcement of two biotech initial public offerings and a special purpose acquisition company transaction. We also look at the development of a new COVID-19 vaccine and decreased U.S. and European investment in Chinese biotech ... READ MORE >
5 things to know in life sciences: Week of Aug. 28, 2023
This week we explore Medicare’s price negotiations, gene therapies to target hearing restoration and an innovative approach to pharmacy benefits management, or PBM. In addition, we look at a medical device that can be used to detect atrial fibrillation and the acquisition of a contract development and ... READ MORE >
5 things to know in life sciences: Week of Aug. 7, 2023
This week, we spotlight the use of an oral pill for postpartum depression, a change in Meta’s approach to artificial intelligence, and an expedited regulatory review process for medical devices. We also delve into major increases in research and development spending among large pharmaceutical companies. ... READ MORE >
5 things to know in life sciences: Week of July 31, 2023
This week we spotlight a groundbreaking wearable ultrasound scanner, the invention of a tiny tentacled robot for potential early lung cancer detection, as well as the appointment of a new director at the National Institute of Allergy and Infectious Diseases. Additionally, we look at the approval of a ... READ MORE >
5 things to know in life sciences: Week of July 17, 2023
This week, we spotlight the U.K.'s delayed association with Horizon Europe and its impact on the medtech sector. We also delve into a novel discovery in MRI imaging and the Food and Drug Administration's approval of a new treatment for preventing the respiratory syncytial virus, known as RSV, in young ... READ MORE >
5 things to know in life sciences: Week of July 10, 2023
This week, we spotlight the use of the DNA segment, known as CRISPR, for HIV treatment. We also delve into the initial public offering plans of two biotech firms. Additionally, we look at a data-driven approach to precision health and a newly Food and Drug Administration-approved miniature insulin pump. ... READ MORE >
5 things to know in life sciences: Week of June 19, 2023
This week we spotlight the significant uptick in biotech layoffs in the first quarter as well as the European Commission's strategic postponement of the new Medical Device Regulation. Additionally, we delve into recent groundbreaking approvals encompassing two innovative oral medications for pediatric ... READ MORE >
5 things to know in life sciences: Week of June 12, 2023
This week we're tracking new COVID-19 booster strategies targeting the XBB variant, Moderna's move into mRNA therapies for rare diseases, U. S. Food and Drug Administration guidelines to safeguard tattoo inks, challenges for European medical device startups, and a Scottish startup's pilot telerobot ... READ MORE >
5 things to know in life sciences: Week of June 5, 2023
This week we highlight a shortage of prescription medication in the United States. In addition, we discuss a Food and Drug Administration committee’s recommendation to approve a new RSV vaccine, comments on the Inflation Reduction Act impact, as well as a major acquisition in the diabetes space. Lastly, ... READ MORE >